Invention Grant
- Patent Title: Anti-TNF compounds
-
Application No.: US16248912Application Date: 2019-01-16
-
Publication No.: US10760080B2Publication Date: 2020-09-01
- Inventor: Christopher C. Mader , Tiffany L. Halo , Sergei Gryaznov , Richard Kang , Weston Daniel
- Applicant: Exicure, Inc.
- Applicant Address: US IL Skokie
- Assignee: Exicure, Inc.
- Current Assignee: Exicure, Inc.
- Current Assignee Address: US IL Skokie
- Agency: Wolf, Greenfield & Sacks, P.C.
- Main IPC: C07H21/04
- IPC: C07H21/04 ; C12N15/113 ; A61K31/7125 ; C07H21/02 ; C07H21/00 ; A61K45/06 ; A61K47/54 ; A61K47/69 ; A61K31/712 ; B82Y5/00
Abstract:
TNFα antisense oligonucleotides are provided herein. Methods of treating TNFα diseases or Initial Screen of Phosphodiester disorders using the TNFα antisense oligonucleotides and related products are provided.
Public/Granted literature
- US20190211338A1 ANTI-TNF COMPOUNDS Public/Granted day:2019-07-11
Information query
